“The latest Cuban drug is now used in the treatment of diabetes” – a news item on Heberprot-P on Russia 24

Nizhny Novgorod, Russia | Wednesday, March 23, 2016

On March 22, Russia 24 had a news item dedicated to Heberprot-P, a drug promoted by IRWIN 2 in the Russian Federation.

Heberprot-Pis a unique Cuban biotechnological drug for the treatment of trophic ulcers in patients with diabetes mellitus, developed by the Center for Genetic Engineering and Biotechnology (Havana).

 

Contacts

News

Distribution

About Us

Warehouse

Partners

Logistics

 

IRWIN 2 OOO belongs to the Pharmeco Group

© IRWIN 2 OOO, 2016

All rights reserved.